DTBA1Q1 Viva Quad XT
Cardiac Resynchronization Therapy - Defibrillation (CRT-Defib)
DTBA1Q1 Viva Quad XT
Information

Device Survival Probability

VIVA_XT_QUAD_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr at 103.0 mo  
% Excluding Normal Battery Depletion 100.0 100.0 99.9 99.9 99.9 99.8 99.8 99.8 99.8  
% Including Normal Battery Depletion 99.9 99.8 99.3 98.1 94.4 85.4 70.2 47.4 26.7  
#   33771 31343 28906 25963 22291 17429 11584 4607 474  
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Product Characteristics

Generator Type CRT-Defib
NBD Code DDE-DDDR
Max. Delivered Energy 36 J
More
Serial Number Prefix BLD
Mass 82 g
Volume 36cc
Waveform Biphasic
X-Ray ID PXT
Hide this content
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 3.6 4.3 4.9 5.3
Quarterly 4.9 6.3 7.8 8.8
Semi-annual 5.2 6.6 8.5 9.6
Footnote

Longevity estimates based on the following device usage. Pacing Mode DDD; Atrial Lower Pacing Rate 60ppm; Ventricular Lower Pacing Rate 60ppm; Atrial Pulse Width 0.4ms; Ventricular Pulse Width 0.4ms; Atrial Pulse Amplitude 3V; Ventricular Pulse Amplitude 3V; Atrial Impedance 510ohms; Ventricle Impedance 510ohms; Atrial Sensing Rate 70bpm; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Integrated bi-ventricular pacing RV+LV; Left Ventricle Impedance 510ohms; Left Ventricular Pulse Width 0.4ms; Left Ventricular Pulse Amplitude 3V; Optivol ON; Atrial Fib percentage of time 0%; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Information

Distribution Data

US Market Release2014-07-03
CE Approval Date
Registered USA Implants21350
Estimated Active USA Implants6175
Normal Battery Depletions2765
US Market Release2014-07-03
CE Approval Date
Estimated WW Distribution24645
Normal Battery Depletions2765
Information

Malfunctions (USA)

Therapy Function Not Compromised 9
Battery 3
Electrical Component 4
Possible Early Battery Depletion 1
Other 1
Therapy Function Compromised 5
Battery 4
Electrical Component 1
Information

Malfunctions (WW)

Therapy Function Not Compromised 9
Battery 3
Electrical Component 4
Possible Early Battery Depletion 1
Other 1
Therapy Function Compromised 5
Battery 4
Electrical Component 1
Information

EOL Indicator

From the point that the RRT is set, the pacemaker will operate for approximately three months for typical pacemaker configurations during the normal operating life.

Information

Recommended Replacement (RRT)

Battery voltage less than or equal to 2.73V on 3 consecutive daily automatic measurements.

Information

Charge Time

BLACKWELL_CRT-D_CHRG
Loading...

Data as of April 30, 2024

www.medtronic.com/productperformance 1001052